About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,495 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,495 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2841-2860 of 7,495 trials

Not yet recruitingCancer Literacy Education and Awareness Resources for Prostate CareThe CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties…NCT07437482·Alicante RecruitingProstate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease PatientsTo evaluate the potential usefulness of 68Ga/18F-PSMA/PSFA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various…NCT06690970·Hefei, Anhui and 2 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedPROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)This study evaluates whether exercise can reduce treatment-related adverse effects in prostate cancer patients initiating androgen deprivation therapy.NCT03776045

CompletedMagneThermoPro : Magnetic Resonance Thermography of Human ProstateThe objective of this project is to offer a very innovative solution for measuring temperature variations in MRI on the prostate.NCT04822272·Bordeaux

CompletedTreatment of Hemorrhagic Radiation Proctitis Using the Halo SystemThis study involves evaluating a procedure in which the study device, the HALO90 Ablation catheter, is used to heat a thin layer of tissue lining the rectum using radiofrequency…NCT01103492·Cleveland, Ohio

CompletedEnhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)This trial tests if AI can help make medical info clear and readable.NCT07568444·Los Angeles, California

CompletedProstate SBRT for Locally Recurrent Prostate Cancer After Prior RadiotherapyBackground: Prostate cancer is the second leading cause of cancer death in United States (U.S.) men.NCT03253744·Bethesda, Maryland

CompletedWeight Management Aimed to Reduce Risk and Improve Outcomes From Radical ProstatectomyThe purpose of this study is to test how a weight management program affects substances in the blood called biomarkers that can show the presence or severity of cancer, compared…NCT03261271·Kansas City, Kansas

TerminatedRegistry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging EvaluationsThe purpose of this observational research registry is to understand the real-world use of Illuccix PET/CT in prostate cancer, and how results from this testing impact patient's…NCT06655064·Fresno, California and 8 others

CompletedTreatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare PopulationThe goal of the study is to provide a detailed description of treatments for CRPC (Castrate Resistant Prostate Cancer) patients with bone metastases and the resource utilization…NCT02518698·Louisville, Kentucky

CompletedAdaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate CancerAbiraterone is approved in the United States by the U.S. Food and Drug Administration (FDA) to treat metastatic prostate cancer at 1000 mg daily.NCT02415621·Tampa, Florida

CompletedUtilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate CaThe purpose of the study is to test genes for BRCAness(BRCA\[BReast CAncer\] gene) Studying these genes could help predict which patients would benefit from treatment with…NCT01289067·New York, New York

Recruiting18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate CancerThis a single-center, prospective, exploratory study.NCT06706921·Los Angeles, California

CompletedLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)The goal of this clinical research study is to find the highest tolerable doses of the combinations of lenalidomide and other drugs that can be given to patients with advanced…NCT01183663·Houston, Texas

RecruitingTrop2-targeted immunoPET Imaging of Solid TumorsThis study aims to establish and optimize the trophoblast cell surface antigen 2 (Trop2)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging…NCT06851663·Shanghai

Active not recruitingAdaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate CancerThis is a prospective single center phase IIa open label nonrandomized study, which aims to test the hypothesis that the duration of castration sensitive phase of stage IV…NCT06734130·Tampa, Florida

CompletedEffects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing ProstatectomyRATIONALE: Tomato-soy juice may slow the growth of tumor cells.NCT01009736·Columbus, Ohio

Not yet recruitingRadical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate CancerThis prospective, open randomized clinical trial seeks to investigate whether radical prostatectomy with androgen deprivation therapy improves prostate-cancer specific survival…NCT04093375

RecruitingLu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)Multicenter, open-label, parallel-group, phase II randomized study in patients with oligometastatic prostate cancer with 1-3 asymptomatic metastases of the soft tissue or bone.NCT05893381·Cesena, FC and 1 other

Active not recruitingIntegrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesBackground: Prostate cancer is one of the most common cancers in men. For some men, their cancer is monitored.NCT04541030·Birmingham, Alabama and 1 other

PreviousPage 143 of 375Next